Cyst Growth Rate Predicts Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasms

Comparison of the Sendai and Fukuoka Consensus Guidelines for the Management of Mucinous Cystic Lesions of the Pancreas: Are We Making Progress?

“…Furthermore, and in line with many other expert centers, cysts that grow at a rate of 2 mm/year or more are of sufficient concern for us to recommend resection; we believe size change should be considered in the development of future consensus guidelines. 8 In summary, the experience of Gho and colleagues adds further substantiating data that the revised Sendai criteria are currently the most appropriate widespread recommendations to adopt at a population level. However, with elimination of cyst size as an absolute criterion for resection of SB-IPMNs must come heightened awareness that a small population of patients will have large, low-risk cysts that may harbor HGD or even invasive malignancy.…”

Acute Pancreatitis is a Predictive Factor for Malignancy in Mixed or Main Duct Intraductal Papillary Mucinous Neoplasms

“…In this study, mixed type IPMN was classified in combination with main duct IPMN [3,15]. Mural nodules were defined as enhanced lesions protruding into the dilated pancreatic duct on contrast-enhanced CT and/or MRI [26].…”

Endoscopic Ultrasonography in Management of Cystic Disease of the Pancreas

“…This role is particularly important in side branch IPMN in which disease progression could vary from patient to another. There is abundant evidence now that smaller side branch IPMN cysts are usually benign and that malignant potential of these cysts is correlating with its size [79]. Three cm in size was proposed as a cut off value in differentiating benign from potentially malignant branch duct IPMN.…”